Cargando…
Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers
BACKGROUND: Neurosurgical resection and whole-brain radiation therapy (WBRT) are accepted treatments for single and oligometastatic cancer to the brain. To avoid the decline in neurocognitive function (NCF) linked to WBRT, the authors conducted a prospective, multicenter, phase 2 study to determine...
Autores principales: | Brem, Steven, Meyers, Christina A, Palmer, Gary, Booth-Jones, Margaret, Jain, Surbhi, Ewend, Matthew G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209121/ https://www.ncbi.nlm.nih.gov/pubmed/24037801 http://dx.doi.org/10.1002/cncr.28307 |
Ejemplares similares
-
Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019) -
Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016) -
Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014) -
Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
por: Manini, Ivana, et al.
Publicado: (2022) -
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)